ArticleThe Prostate2026

Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial.

Braden Millan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.